Clinical Trials Browser

Phase NA × Lymphoma × Bortezomib × Clear all

NCT00772668 2017-12-11

Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL

Phase NA Terminated

3 enrolled 6 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone